Simone Bertz

3.3k total citations
87 papers, 1.9k citations indexed

About

Simone Bertz is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Simone Bertz has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 31 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Simone Bertz's work include Bladder and Urothelial Cancer Treatments (55 papers), Urinary and Genital Oncology Studies (42 papers) and Epigenetics and DNA Methylation (11 papers). Simone Bertz is often cited by papers focused on Bladder and Urothelial Cancer Treatments (55 papers), Urinary and Genital Oncology Studies (42 papers) and Epigenetics and DNA Methylation (11 papers). Simone Bertz collaborates with scholars based in Germany, United States and Switzerland. Simone Bertz's co-authors include Arndt Hartmann, Stefan Denzinger, Bernd Wullich, Wolfgang Otto, Robert Stoehr, Maximilian Burger, Wolf F. Wieland, Robert Stöhr, James W.F. Catto and Michael Stöckle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Simone Bertz

84 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simone Bertz Germany	25	1.2k	648	460	421	330	87	1.9k
Catherine Mazerolles France	22	635 0.5×	517 0.8×	276 0.6×	195 0.5×	185 0.6×	59	1.4k
Marcia L. Wills United States	22	317 0.3×	698 1.1×	438 1.0×	681 1.6×	192 0.6×	43	1.6k
Abha Khanna United States	12	504 0.4×	764 1.2×	761 1.7×	352 0.8×	402 1.2×	28	1.8k
Elaina M. Gartner United States	18	683 0.6×	430 0.7×	964 2.1×	281 0.7×	116 0.4×	40	1.7k
Pramila Ramani United Kingdom	21	477 0.4×	533 0.8×	276 0.6×	308 0.7×	180 0.5×	48	1.4k
Simona Gurzu Romania	21	420 0.4×	487 0.8×	671 1.5×	336 0.8×	316 1.0×	165	1.6k
Kurt R. Weiss United States	23	306 0.3×	770 1.2×	431 0.9×	445 1.1×	323 1.0×	79	1.8k
Brigitta Omazic Sweden	13	357 0.3×	258 0.4×	338 0.7×	119 0.3×	82 0.2×	19	1.5k
Stephen J. Elliman Ireland	14	225 0.2×	416 0.6×	364 0.8×	146 0.3×	129 0.4×	26	1.1k
Orhan G. Yigitbasi Türkiye	18	187 0.2×	303 0.5×	323 0.7×	286 0.7×	94 0.3×	49	982

Countries citing papers authored by Simone Bertz

Since Specialization

Citations

This map shows the geographic impact of Simone Bertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Bertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Bertz more than expected).

Fields of papers citing papers by Simone Bertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Bertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Bertz. The network helps show where Simone Bertz may publish in the future.

Co-authorship network of co-authors of Simone Bertz

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Bertz. A scholar is included among the top collaborators of Simone Bertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Bertz. Simone Bertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geppert, Carol I., Simone Bertz, Robert Stöhr, et al.. (2024). Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 769–779.

Eckstein, Markus, Rudolf Jung, Verena Lieb, et al.. (2024). Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients. International Journal of Molecular Sciences. 25(12). 6325–6325. 3 indexed citations

Lang‐Schwarz, Corinna, Maike Büttner‐Herold, Ramona Erber, et al.. (2023). Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact. Journal of Clinical Pathology. 78(2). 103–110. 10 indexed citations

Ortiz‐Brüchle, Nadina, Michael Rose, Simone Bertz, et al.. (2021). Molecular Characterization of Muellerian Tumors of the Urinary Tract. Genes. 12(6). 880–880. 7 indexed citations

Eckstein, Markus, Verena Lieb, Rudolf Jung, et al.. (2021). Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells. 10(7). 1796–1796. 3 indexed citations

Bertz, Simone, Armin Ensser, Robert Stoehr, et al.. (2020). Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas. Modern Pathology. 33(7). 1433–1442. 9 indexed citations

Weyerer, Veronika, Evgeny A. Moskalev, Florian Haller, et al.. (2019). Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma. Histopathology. 75(6). 865–875. 29 indexed citations

Putte, Elisabeth E. Fransen van de, Judith Bosschieter, Theodorus van der Kwast, et al.. (2018). The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer. British Journal of Urology. 122(6). 978–985. 23 indexed citations

Zinnall, Ulrike, Veronika Weyerer, Éva Compérat, et al.. (2018). Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. Human Pathology. 80. 55–64. 43 indexed citations

10.

Hofheinz, Katharina, Simone Bertz, Jochen Wacker, Georg Schett, & Bernhard Manger. (2017). Fever of unknown origin, giant cell arteritis, and aortic dissection. Zeitschrift für Rheumatologie. 76(1). 83–86. 1 indexed citations

11.

Stoehr, Robert, Antonia Wenners, Arndt Hartmann, et al.. (2016). Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis. 5(2). e205–e205. 3 indexed citations

12.

Jackson, Carolyn C., Lazaro Lorenzo, Jean‐Laurent Casanova, et al.. (2015). A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression. Journal of Clinical Immunology. 36(1). 19–27. 9 indexed citations

13.

Drayton, Ross M., Ewa Dudziec, Stefán Péter, et al.. (2014). Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11. Clinical Cancer Research. 20(7). 1990–2000. 189 indexed citations

14.

Hartmann, Arndt, Thorsten Schlomm, Simone Bertz, et al.. (2014). Prognostische und prädiktive molekulare Marker urologischer Tumoren. Der Urologe. 53(4). 491–500. 4 indexed citations

15.

Keck, Bastian, Sven Wach, Peter J. Goebell, et al.. (2013). SNAI1 Protein Expression is an Independent Negative Prognosticator in Muscle-Invasive Bladder Cancer. Annals of Surgical Oncology. 20(11). 3669–3674. 10 indexed citations

16.

Keck, Bastian, Sven Wach, Robert Stoehr, et al.. (2013). Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer. 13(1). 71–71. 57 indexed citations

17.

Walter, Bernhard, Arndt Hartmann, Ferdinand Hofstädter, et al.. (2012). Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 460(3). 343–352. 8 indexed citations

18.

Hoffmann, Andreas-Claudius, Peter J. Wild, Simone Bertz, et al.. (2010). MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy. Neoplasia. 12(8). 628–636. 106 indexed citations

19.

Weckermann, Dorothea, Bernhard Polzer, Thomas Ragg, et al.. (2009). Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer. Journal of Clinical Oncology. 27(10). 1549–1556. 118 indexed citations

20.

Stoehr, Robert, C. Adam, Simone Bertz, et al.. (2006). FGFR3 mutation analysis in flat urothelial hyperplasia - strong evidence for chromosome 9 deletions as the earliest genetic alterations in the development of papillary bladder cancer. Cancer Research. 66. 81–81. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact